United States (USA) Blood Glucose Monitor Market Overview, 2031

The blood pressure monitoring device market in the United States has undergone considerable transformation as healthcare moved from hospital-focused approaches to home care and remote patient monitoring, a development that has also affected trends. The rising incidence of hypertension linked to lifestyle choices, obesity, and heart-related diseases has widened the role of blood pressure monitoring devices from mere diagnosis to ongoing management and prevention. Initially, the market consisted of manual mercury and aneroid sphygmomanometers that were only used in healthcare facilities. As time passed, worries regarding mercury safety, the need for user-friendliness, and self-monitoring by patients prompted the launch of digital oscillometric devices for home use and outpatient clinics. In recent years, advancements have sped up toward connected, wearable, and cuffless devices that integrate with smartphones and cloud services. These devices typically assess arterial pressure using oscillometric sensors or algorithms based on optics and pulse transit time found in sophisticated wearables, converting body signals into systolic and diastolic measurements. Clinically, they have shown effectiveness in enhancing awareness of hypertension, adherence to medications, and early treatment by facilitating frequent readings away from clinical settings. Significant investment in research and development from U.S. manufacturers and tech companies is directed towards cloud connectivity, artificial intelligence-enabled analytics, integration with electronic health records, and remote patient monitoring platforms that facilitate clinician oversight. Regulatory and compliance rules are vital to the market's progression. The FDA's 510k approval guarantees device safety and precision, HIPAA protects patient data privacy and cybersecurity issues, and ISO standards ensure quality management and performance continuity. These regulations foster clinical confidence, safeguard patient information, and support widespread adoption across healthcare systems.

According to the research report, " US Blood Pressure Monitoring Devices Market Overview, 2031," published by Bonafide Research, the US Blood Pressure Monitoring Devices market was valued at more than USD 1.63 Billion in 2025. The U.S. blood pressure monitoring device market stands as one of the largest and most developed segments backed by a consistent compound annual growth rate resulting from chronic disease rates, an aging population, and the uptake of digital health solutions. Recent growth in the market has been bolstered by policy changes, especially the Medicare coverage for remote patient monitoring, encouraging providers to recommend at-home blood pressure devices as part of chronic disease management initiatives. Further spurred demand by normalizing telehealth services and at-home health checks, trends that continue to influence buying habits. Major players in the U.S. market include well-known medical device manufacturers, consumer health brands, and new digital health firms providing validated upper-arm monitors, wearable blood pressure devices, and solutions enabled for remote patient monitoring. These companies set themselves apart through clinical precision, FDA approval, capabilities for data integration, and collaborations with healthcare providers and insurers. The market increasingly combines devices with software dashboards, analytics, and management services instead of solely standalone hardware. There are significant prospects as the healthcare landscape shifts toward value-based care models that favor patient outcomes rather than the volume of services. The growth of telehealth, employer-funded wellness initiatives, and the rising focus on managing population health stimulate ongoing demand for scalable blood pressure monitoring solutions. Moreover, incorporating blood pressure monitoring into wider chronic disease management frameworks prepares the market for further expansion as healthcare institutions emphasize preventive care and long-term cost savings.

US blood pressure monitoring devices market by product type is divided into sphygmomanometers manual/aneroid devices, digital blood pressure monitors automated, ambulatory blood pressure monitors ABPM, blood pressure transducers. The market for blood pressure monitoring devices in the United States is significantly influenced by advances in technology, standards for clinical precision, and the need for convenient options among consumers. Manual and aneroid sphygmomanometers still have a significant presence in hospitals, doctors' practices, and emergency medical scenarios due to their reliability, cost-effectiveness, and familiarity among medical professionals. Nevertheless, their usage is slowly decreasing in non-clinical settings as automated devices become more popular. Digital blood pressure monitors constitute the largest and most rapidly expanding segment of this market, largely because of their widespread use in home healthcare and outpatient monitoring. These devices come equipped with features like Bluetooth connectivity, smartphone compatibility, AI-based trend tracking, and FDA approval, making them appealing to both consumers and healthcare providers. Ambulatory Blood Pressure Monitors ABPM are seeing increased usage for diagnosing hypertension, identifying white-coat syndrome, and assessing long-term cardiovascular risk, particularly in cardiology and specialized clinics. Their use is also advocated by clinical guidelines that highlight the need for continuous monitoring to ensure accurate diagnoses. Blood pressure transducers, although a smaller segment, play a vital role in intensive care units, surgical rooms, and catheter labs where real-time invasive blood pressure measurements are essential. The U.S. market landscape displays rapid innovation, premium pricing, and a significant emphasis on data-driven and interconnected healthcare solutions.

US blood pressure monitoring devices market by end user is divided into hospitals & clinics, home healthcare, diagnostic centers and others. The U.S. blood pressure monitoring devices market is primarily led by hospitals and clinics, which benefit from high patient numbers, well-developed infrastructure, and robust reimbursement policies. These healthcare facilities use a variety of manual, digital, and invasive monitoring systems to facilitate emergency services, surgical procedures, management of chronic conditions, and routine diagnostic tests. Home healthcare is emerging as the fastest-growing end-user segment, driven by the increasing prevalence of hypertension, an aging population, and a trend towards value-driven and remote care models. Consumers are showing a growing preference for digital monitors that enable self-testing, information sharing with doctors, and tracking health over the long term. Diagnostic centers also comprise a key end-user segment, particularly for ABPM devices in cardiovascular assessments and preventive health checkups. These centers are capitalizing on the rising awareness regarding the early detection of hypertension and health programs supported by employers. The Others category, which includes ambulatory care facilities, nursing homes, and telehealth services, is also growing as decentralized healthcare becomes more prevalent. In the U.S., strong insurance coverage, support from Medicare for chronic disease monitoring, and consumers' willingness to invest in health technologies are key factors shaping end-user adoption trends, leading to a highly varied and competitive market.

US blood pressure monitoring devices market by distribution channel is divided into retail channels, institutional sales and direct-to-consumer DTC. Distribution methods in the U.S. market for blood pressure monitoring devices are very diverse and led by consumer needs. Retail options, such as pharmacies, large retail chains, and medical supply shops, continue to be significant sales channels, particularly for digital monitors intended for home use. These stores gain from brand recognition, in-store deals, and customer confidence. Sales made to institutions comprise a considerable portion, as hospitals, clinics, and diagnostic facilities obtain devices through bulk buying contracts, group purchasing entities, and long-term supplier agreements. Direct-to-Consumer DTC methods are growing swiftly, fueled by online shopping sites, manufacturer platforms, and digital health companies. Shoppers are increasingly leaning towards buying online because of ease, tools to compare products, subscription monitoring options, and combined telehealth services. Clear regulations, robust logistics networks, and high levels of internet access further encourage DTC growth. In the U.S., distribution plans focus on speed, availability, and customization, with producers making significant investments in digital advertising and holistic sales strategies to reach both institutional and personal purchasers.



"Considered in this report
• Historic Year: 2020
• Base year: 2025
• Estimated year: 2026
• Forecast year: 2031
Aspects covered in this report
• Blood Glucose Monitoring Devices Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation
By Product Type
• Sphygmomanometers (Manual/Aneroid Devices)
• Digital Blood Pressure Monitors (Automated)
• Ambulatory Blood Pressure Monitors (ABPM)
• Blood Pressure Transducers

By End User
• Hospitals & Clinics
• Home Healthcare
• Diagnostic Centers
• Others

By Technology
• Connected/Bluetooth-enabled Monitors
• Smart/Wi-Fi-enabled Monitors
• Traditional/Standalone Monitors

By Distribution Channel
• Retail Channels
• Institutional Sales
• Direct-to-Consumer (DTC)"